The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*
Abstract
BACKGROUND: Short-term studies have suggested that sevelamer hydrochloride, a non-aluminium- and non-calcium-containing hydrogel, is an effective phosphate binder in haemodialysis patients, and may produce favourable changes in the lipid profile. METHODS: To determine the long-term effectiveness of sevelamer hydrochloride, we performed an open-label clinical trial in 192 adult patients with end-stage renal disease on haemodialysis. Drug-related changes in the concentrations of serum phosphorus, calcium, calcium x phosphate product, parathyroid hormone, and low- and high-density lipoprotein cholesterol concentrations were the major outcomes of interest. RESULTS: Treatment with sevelamer was associated with a mean change in serum phosphorus of -0.71+/-0.77 mmol/l, serum calcium of 0. 08+/-0.22 mmol/l, and calcium x phosphate product of -1.46+/-1.78 mmol/l (P<0.0001 for all comparisons). There were no significant overall treatment-related changes in parathyroid hormone. Serum levels of LDL cholesterol decreased by 0.81+/-0.75 mmol/l (mean -30%, P<0.0001) and HDL cholesterol increased by a mean of 0.15+/-0.29 mmol/l (mean +18%, P<0.0001). Drug-related adverse events were infrequent and most were of mild intensity. CONCLUSION: Sevelamer is a safe and effective phosphate binder that leads to significant improvements in the calcium x phosphate product and lipid profile of haemodialysis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Block, G., Hulbert-Shearon, T., Levin, N., & Port, F. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531176 · Cited by 2,354
Lowrie, E. G., & Lew, N. L. (1990) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)70364-5 · Cited by 1,976
Poor Long-Term Survival after Acute Myocardial Infarction among Patients on Long-Term Dialysis
Herzog, C. A., Ma, J. Z., & Collins, A. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391203 · Cited by 885
Slatopolsky, E., Finch, J., Denda, M., Ritter, C., Zhong, M., Dusso, A., MacDonald, P. N., & Brown, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118701 · Cited by 511
Self-citationRao, D. S., Shih, M.-S., & Mohini, R. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280304 · Cited by 390
Calcium Carbonate as a Phosphate Binder in Patients with Chronic Renal Failure Undergoing Dialysis
Slatopolsky, E., Weerts, C., Lopez-Hilker, S., Norwood, K., Zink, M., Windus, D., & Delmez, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198607173150304 · Cited by 379
Self-citationC-reactive protein as an outcome predictor for maintenance hemodialysis patients
Owen, W. F. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00032.x · Cited by 378
Bleyer, A. J., Burke, S. K., Dillon, M., Garrett, B., Kant, K. S., Lynch, D., Rahman, S. N., Schoenfeld, P., Teitelbaum, I., Zeig, S., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70221-0 · Cited by 274
Self-citationCardiovascular Risk Factors in Chronic Renal Failure and Hemodialysis Populations
Ma, K. W., Greene, E. L., & Raij, L. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80827-4 · Cited by 269
Cited by
Qunibi, W., Moustafa, M., Muenz, L. R., He, D. Y., Kessler, P. D., Diaz-Buxo, J. A., & Budoff, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.298 · Cited by 311
Metabolic Bone Disease in Chronic Kidney Disease
Martin, K. J., & González, E. A. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070771 · Cited by 288
Townsend, R., Elliott-Sale, K. J., Pinto, A. J., Thomas, C., Scott, J. P. R., Currell, K., Fraser, W. D., & Sale, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1848 · Cited by 39
Metadata
- Authors
- Chertow, G. M., Burke, S. K., Dillon, M. A., & Slatopolsky, E.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12-01
- Volume
- 14
- Issue
- 12
- Pages
- 2907-2914
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2110693651
- Cited by
- 296
- References
- 19
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*. https://app.cochat.ai/papers/10.1093/ndt/14.12.2907
- The paper
- Chertow, G. M., Burke, S. K., Dillon, M. A., & Slatopolsky, E. (1999). Long-term effects of sevelamer hydrochloride on the calcium × phosphate product and lipid profile of haemodialysis patients*. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/14.12.2907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.